Breast cancer risk remains elevated 20-30 years after childbirth
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2019/1/feature/1-feature-breast-cancer/thumb859874.jpg?itok=CWrYyDmL" /><br /><p>New research shows pregnancy first elevates breast cancer risk, but becomes protective over time.</p> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news

Pregnancy After Breast Cancer Is Safe, Landmark Study Says
Initial results from a new study show women who paused protective post-cancer therapies to get pregnant had no increased risk of their cancer coming back. Nearly 3 in 4 women in the study got pregnant, and 64% had a live birth. (Source: WebMD Health)
Source: WebMD Health - January 5, 2023 Category: Consumer Health News Source Type: news

ER+ Breast Cancer Data: SERDs, Pregnancy, and New Targets ER+ Breast Cancer Data: SERDs, Pregnancy, and New Targets
Kathy D. Miller, MD, and Kevin Kalinsky, MD, discuss recent studies important for treating patients with ER-positive disease.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 3, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

SABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
Findings seen among young women with early - stage, hormone receptor - positive breast cancer desiring pregnancy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 14, 2022 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Conference News, Source Type: news

SABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
WEDNESDAY, Dec. 14, 2022 -- For young women with early-stage hormone receptor (HR)-positive breast cancer (BC) desiring pregnancy, temporary interruption of endocrine therapy does not confer a greater short-term risk for recurrence than not... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2022 Category: Pharmaceuticals Source Type: news

Women Can Safely Interrupt Endocrine Tx to Pursue Pregnancy Women Can Safely Interrupt Endocrine Tx to Pursue Pregnancy
Interrupting endocrine therapy may allow three quarters of women with hormone receptor positive breast cancer to achieve pregnancy, while having no impact on their short-term outcomes, new data suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breast Cancer Survivors Can Safely Pause Longer - Term Meds During Pregnancy
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 8, 2022 Category: Cancer & Oncology Tags: Oncology, Obstetrics, News, Source Type: news

For Camp Lejeune Victims Exposed to Toxic Water, a New Law Promises Compensation —and Closure
Many of Ann Johnson’s life milestones were marked at Camp Lejeune, a sprawling U.S. Marine Corps base camp on the North Carolina coast. She moved to the base in 1982, when her stepfather was stationed there. In 1983, she graduated from Camp Lejeune High School. In 1984, she got married and, at the age of 18, gave birth to her first child at the on-base hospital. Johnson had a difficult pregnancy, gaining 120 pounds due to a complication that leads to excess amniotic fluid. In retrospect, she says, this was the first sign that something was wrong. Then, on the day her daughter, Jacquetta, was born, she didn’t cr...
Source: TIME: Health - November 16, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Source Type: news

Previous Breast Cancer Doesn't Increase Poor Pregnancy Outcomes Previous Breast Cancer Doesn't Increase Poor Pregnancy Outcomes
A cancer diagnosis did not disrupt the health of newborns and mothers, the study found, but many pregnant women with cancer still chose C-section.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 12, 2022 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health News Source Type: news

After Roe, Pregnant Women With Cancer Diagnoses May Face Wrenching Choices
Urgent questions arise about how care of pregnant women with cancer will change in states where women are unable to terminate pregnancies (Source: NYT Health)
Source: NYT Health - July 23, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: Pregnancy and Childbirth Abortion Breast Cancer Drugs (Pharmaceuticals) Source Type: news

The Politicization of Fetal Viability
The fall of Roe v. Wade on June 24 marked the start of a strange era to be a Maternal-Fetal Medicine physician. By definition, we take care of anyone with a high-risk pregnancy, which can occur because the pregnant person has a medical condition such as diabetes or breast cancer or because something is wrong with the fetus genetically or anatomically, like a birth defect. As high-risk pregnancy physicians, we share the mantra that we hope for the best but prepare for the worst. Luckily, of the thousands of patients we have cared over the last 12 years, the majority have achieved our hope of the best: a relatively uneventfu...
Source: TIME: Health - July 14, 2022 Category: Consumer Health News Authors: Adam Lewkowitz and Nina Ayala Tags: Uncategorized abortion freelance Source Type: news

How Fetal Viability Is Misunderstood
The fall of Roe v. Wade on June 24 marked the start of a strange era to be a Maternal-Fetal Medicine physician. By definition, we take care of anyone with a high-risk pregnancy, which can occur because the pregnant person has a medical condition such as diabetes or breast cancer or because something is wrong with the fetus genetically or anatomically, like a birth defect. As high-risk pregnancy physicians, we share the mantra that we hope for the best but prepare for the worst. Luckily, of the thousands of patients we have cared over the last 12 years, the majority have achieved our hope of the best: a relatively uneventfu...
Source: TIME: Health - July 14, 2022 Category: Consumer Health News Authors: Adam Lewkowitz and Nina Ayala Tags: Uncategorized abortion freelance Source Type: news

Studying animal evolution to advance women ’s health
Breast cancer, osteoporosis and infertility don ’t just affect women — they also strike animals across the female tree of life.Yet many species have developed physical changes over millions of years that protect them from these conditions, begging the question: What if the key to preventing these and other disorders lies untapped in the animal king — er, queendom? That ’s the crux of a new UCLA paperpublished in PNAS Nexus that  summarizes years of research measuring females ’ risk for common diseases across different species. The authors — a physician, an evolutionary biologist and a veterinarian — teamed...
Source: UCLA Newsroom: Health Sciences - May 31, 2022 Category: Universities & Medical Training Source Type: news